Cancer Tissue Gallery- GTX04399

CD66e antibody [MSVA-465R] HistoMAX

Adenocarcinoma of the lung showing strong CD66e immunostaining in tumor cells.

Adenocarcinoma of the pancreas with strong CD66e immunostaining in all tumor cells.

Cholangiocellular carcinoma of the liver showing strong CD66e immunostaining in tumor cells.

Colorectal adenocarcinoma with strong CD66e positivity in tumor cells.

Diffuse type stomach cancer with strong CD66e immunostaining of all tumor cells.

Hepatocellular carcinoma completely lacking CD66e immunostaining.

Intestinal type stomach cancer with moderate to strong CD66e immunostaining of tumor cells.

Malignant mesothelioma not showing any CD66e immunostaining.

Medullary thyroid cancer with strong CD66e immunostaining in all tumor cells.

Moderate to strong CD66e positivity in a mucinous carcinoma of the ovary.

Strong CD66e immunostaining in <50% of cells of a squamous cell carcinoma of the larynx.

Strong CD66e immunostaining in about 60% of cells of a squamous cell carcinoma of the larynx.

Strong CD66e immunostaining in about 80% of cells of a squamous cell carcinoma of the uterine cervix.

Weak to moderate CD66e immunostaining in a lobular breast cancer.